{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T23:17:40Z","timestamp":1790291860774,"version":"4.1.0"},"reference-count":56,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2025,1,13]],"date-time":"2025-01-13T00:00:00Z","timestamp":1736726400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["NCD\/Adhoc\/207\/2022-2023"],"award-info":[{"award-number":["NCD\/Adhoc\/207\/2022-2023"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,6,30]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n               <jats:p>Cardiorenal syndrome (CRS) is represented as an intricate dysfunctional interplay between the heart and kidneys, marked by cardiorenal inflammation and fibrosis. Unlike other organs, the repair process in cardiorenal injury involves a regenerative phase characterized by proliferation and polyploidization, followed by a subsequent pathogenic phase of fibrosis. In CRS, acute or chronic cardiorenal injury leads to hyperactive inflammation and fibrotic remodeling, associated with injury-mediated immune cell (macrophages, monocytes and T cells) infiltration and myofibroblast activation. An inflammatory to fibrotic transition corresponds with macrophage transition (M1\u2013M2) associated with increased transforming growth factor (TGF)-\u03b2 response. Chronic inflammation disrupts hemodynamic pathways, leading to imbalanced oxidative stress and the production of cytokines and growth factors that promote fibrotic stimulation, contributing to pathological cardiorenal remodeling. The inflammatory response paves the pre-fibrotic cardiorenal niche and drives subsequent fibrotic remodeling by activated myofibroblasts. A fibrotic cardiorenal response in CRS is characterized by increased and degradation-resistant deposition of extracellular proteins, especially fibrillar Collagen -I, -III and -V, and non-fibrillar Collagen-IV by active myofibroblasts. Recent advances in basic research animal models of CRS have advanced the knowledge of cardiorenal fibrosis. However, a significant need for clinical applications, trials and evaluation is still needed. Circulating biomarkers like procollagen peptides and TGF-\u03b2 have clinically been associated with cardiorenal fibrosis diagnosis in CRS. Treatments targeting the fibrotic pathways have also shown efficacy in amelioration of cardiorenal fibrosis in preclinical models. Recent combination therapies targeting multiple fibrotic pathways have been shown to offer promising results. Thus, a understanding of the heterogenic pathological progression and fibrogenesis could identify novel therapeutic approaches for clinical CRS diagnosis and treatment.<\/jats:p>","DOI":"10.1093\/ndt\/gfaf009","type":"journal-article","created":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T02:52:02Z","timestamp":1736823122000},"page":"1273-1283","source":"Crossref","is-referenced-by-count":10,"title":["Tissue fibrosis in cardiorenal syndrome: crosstalk between heart and kidneys"],"prefix":"10.1093","volume":"40","author":[{"given":"Abhi","family":"Dutta","sequence":"first","affiliation":[{"name":"Indian Institute of Technology (IIT) School of Biosciences and Bioengineering, , Mandi, Himachal Pradesh ,","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanchari","family":"Chakraborty","sequence":"additional","affiliation":[{"name":"Indian Institute of Technology (IIT) School of Biosciences and Bioengineering, , Mandi, Himachal Pradesh ,","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antara","family":"Roy","sequence":"additional","affiliation":[{"name":"Indian Institute of Technology (IIT) School of Biosciences and Bioengineering, , Mandi, Himachal Pradesh ,","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anupam","family":"Mittal","sequence":"additional","affiliation":[{"name":"Postgraduate Institute of Medical Education and Research Department of Translational and Regenerative Medicine, , Chandigarh ,","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trayambak","family":"Basak","sequence":"additional","affiliation":[{"name":"Indian Institute of Technology (IIT) School of Biosciences and Bioengineering, , Mandi, Himachal Pradesh ,","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,1,13]]},"reference":[{"key":"2025063007571663200_bib1","doi-asserted-by":"publisher","first-page":"e840","DOI":"10.1161\/CIR.0000000000000664","article-title":"Cardiorenal syndrome: classification, pathophysiology, diagnosis, and treatment strategies: a scientific statement from the American Heart Association","volume":"139","author":"Rangaswami","year":"2019","journal-title":"Circulation"},{"key":"2025063007571663200_bib2","doi-asserted-by":"publisher","first-page":"2137","DOI":"10.1007\/s10741-022-10218-w","article-title":"Cardiorenal syndrome: long road between kidney and heart","volume":"27","author":"Junho","year":"2022","journal-title":"Heart Fail Rev"},{"key":"2025063007571663200_bib3","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1002\/ejhf.3210","article-title":"Identification and outcomes of KDIGO-defined chronic kidney disease in 1.4 million U.S. Veterans with heart failure","volume":"26","author":"Patel","year":"2024","journal-title":"Eur J Heart Fail"},{"key":"2025063007571663200_bib4","doi-asserted-by":"crossref","first-page":"e280","DOI":"10.1161\/CIR.0000000000001273","article-title":"Evaluation and management of kidney dysfunction in advanced heart failure: a scientific statement from the American Heart Association","volume":"150","author":"Tang","year":"2024","journal-title":"Circulation"},{"key":"2025063007571663200_bib5","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/s41581-024-00820-6","article-title":"Chronic kidney disease and the global public health agenda: an international consensus","volume":"20","author":"Francis","year":"2024","journal-title":"Nat Rev Nephrol"},{"key":"2025063007571663200_bib6","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1016\/j.jacc.2008.07.051","article-title":"Cardiorenal syndrome","volume":"52","author":"Ronco","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"2025063007571663200_bib7","doi-asserted-by":"publisher","first-page":"1152055","DOI":"10.3389\/fphar.2023.1152055","article-title":"A comprehensive review of acute cardio-renal syndrome: need for novel biomarkers","volume":"14","author":"Dutta","year":"2023","journal-title":"Front Pharmacol"},{"key":"2025063007571663200_bib8","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1161\/CIRCULATIONAHA.117.028814","article-title":"Cardiorenal syndrome revisited","volume":"138","author":"Zannad","year":"2018","journal-title":"Circulation"},{"key":"2025063007571663200_bib9","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1002\/path.2277","article-title":"Cellular and molecular mechanisms of fibrosis","volume":"214","author":"Wynn","year":"2008","journal-title":"J Pathol"},{"key":"2025063007571663200_bib10","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1038\/nm.2807","article-title":"Mechanisms of fibrosis: therapeutic translation for fibrotic disease","volume":"18","author":"Wynn","year":"2012","journal-title":"Nat Med"},{"key":"2025063007571663200_bib11","doi-asserted-by":"publisher","first-page":"e1424","DOI":"10.1097\/TXD.0000000000001424","article-title":"Value of renal histology in predicting cardiorenal outcomes in heart transplant-listed patients","volume":"9","author":"Barua","year":"2023","journal-title":"Transplant Direct"},{"key":"2025063007571663200_bib12","doi-asserted-by":"publisher","first-page":"e029492","DOI":"10.1161\/JAHA.123.029492","article-title":"Cardiovascular magnetic resonance in survivors of critical illness: cardiac abnormalities are associated with acute kidney injury","volume":"12","author":"Isaak","year":"2023","journal-title":"J Am Heart Assoc"},{"key":"2025063007571663200_bib13","doi-asserted-by":"publisher","first-page":"e001598","DOI":"10.1161\/JAHA.114.001598","article-title":"Apocynin attenuates cardiac injury in type 4 cardiorenal syndrome via suppressing cardiac fibroblast growth factor-2 with oxidative stress inhibition","volume":"4","author":"Liu","year":"2015","journal-title":"J Am Heart Assoc"},{"key":"2025063007571663200_bib14","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/j.jacbts.2019.06.005","article-title":"Acute kidney injury induces remote cardiac damage and dysfunction through the Galectin-3 pathway","volume":"4","author":"Prud'homme","year":"2019","journal-title":"JACC Basic Transl Sci"},{"key":"2025063007571663200_bib15","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1159\/000341651","article-title":"Accelerated renal fibrosis in cardiorenal syndrome is associated with long-term increase in urine neutrophil gelatinase-associated lipocalin levels","volume":"36","author":"Entin-Meer","year":"2012","journal-title":"Am J Nephrol"},{"key":"2025063007571663200_bib16","doi-asserted-by":"publisher","first-page":"H1884","DOI":"10.1152\/ajpheart.00967.2011","article-title":"Myocardial infarction impairs renal function, induces renal interstitial fibrosis, and increases renal KIM-1 expression: implications for cardiorenal syndrome","volume":"302","author":"Lekawanvijit","year":"2012","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2025063007571663200_bib17","doi-asserted-by":"publisher","first-page":"16219","DOI":"10.1038\/s41598-021-95695-z","article-title":"Urine peptidome analysis in cardiorenal syndrome reflects molecular processes","volume":"11","author":"Petra","year":"2021","journal-title":"Sci Rep"},{"key":"2025063007571663200_bib18","doi-asserted-by":"publisher","first-page":"2982","DOI":"10.18632\/aging.202448","article-title":"Excessive fibroblast growth factor 23 promotes renal fibrosis in mice with type 2 cardiorenal syndrome","volume":"13","author":"Hao","year":"2021","journal-title":"Aging"},{"key":"2025063007571663200_bib19","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.3389\/fphar.2019.01267","article-title":"Time course of the effects of Buxin Yishen decoction in promoting heart function and inhibiting the progression of renal fibrosis in myocardial infarction caused type 2 cardiorenal syndrome rats","volume":"10","author":"Qiu","year":"2019","journal-title":"Front Pharmacol"},{"key":"2025063007571663200_bib20","first-page":"250","article-title":"The guanylate cyclase C agonist linaclotide ameliorates the gut-cardio-renal axis in an adenine-induced mouse model of chronic kidney disease","volume":"35","author":"Nanto-Hara","year":"2020","journal-title":"Nephrol Dial Transplant"},{"key":"2025063007571663200_bib21","doi-asserted-by":"publisher","first-page":"e165172","DOI":"10.1172\/jci.insight.165172","article-title":"Circulating extracellular vesicles in human cardiorenal syndrome promote renal injury in a kidney-on-chip system","volume":"8","author":"Chatterjee","year":"2023","journal-title":"JCI Insight"},{"key":"2025063007571663200_bib22","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1002\/ehf2.12218","article-title":"Rationale of the FIBROTARGETS study designed to identify novel biomarkers of myocardial fibrosis","volume":"5","author":"Ferreira","year":"2018","journal-title":"ESC Heart Fail"},{"key":"2025063007571663200_bib23","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1016\/j.jacc.2012.01.077","article-title":"Cardiorenal syndrome type 1: pathophysiological crosstalk leading to combined heart and kidney dysfunction in the setting of acutely decompensated heart failure","volume":"60","author":"Ronco","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"2025063007571663200_bib24","doi-asserted-by":"publisher","first-page":"2027","DOI":"10.34067\/KID.0004812022","article-title":"Baroreceptor sensitivity in individuals with CKD and heart failure","volume":"3","author":"Charytan","year":"2022","journal-title":"Kidney360"},{"key":"2025063007571663200_bib25","doi-asserted-by":"publisher","first-page":"S19","DOI":"10.1038\/ki.2008.512","article-title":"Myocardial fibrosis in chronic kidney disease: potential benefits of torasemide","volume":"74","author":"Lopez","year":"2008","journal-title":"Kidney Int"},{"key":"2025063007571663200_bib26","doi-asserted-by":"crossref","first-page":"bcr2012008103","DOI":"10.1136\/bcr-2012-008103","article-title":"Unforeseen renal pathological findings in a patient with type 2 cardiorenal syndrome who died after 4 years of continuous ambulatory peritoneal dialysis","volume":"2013","author":"Matsui","year":"2013","journal-title":"BMJ Case Rep"},{"key":"2025063007571663200_bib27","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1161\/CIRCRESAHA.115.306565","article-title":"Cardiac fibrosis: the fibroblast awakens","volume":"118","author":"Travers","year":"2016","journal-title":"Circ Res"},{"key":"2025063007571663200_bib28","doi-asserted-by":"publisher","first-page":"F569","DOI":"10.1152\/ajprenal.00476.2020","article-title":"Activation of hypoxia-sensing pathways promotes renal ischemic preconditioning following myocardial infarction","volume":"320","author":"Terker","year":"2021","journal-title":"Am J Physiol Renal Physiol"},{"key":"2025063007571663200_bib29","doi-asserted-by":"publisher","first-page":"F388","DOI":"10.1152\/ajprenal.00419.2019","article-title":"Effects of a prolyl hydroxylase inhibitor on kidney and cardiovascular complications in a rat model of chronic kidney disease","volume":"318","author":"Uchida","year":"2020","journal-title":"Am J Physiol Renal Physiol"},{"key":"2025063007571663200_bib30","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1161\/01.HYP.36.4.517","article-title":"Transforming growth factor beta in hypertensives with cardiorenal damage","volume":"36","author":"Laviades","year":"2000","journal-title":"Hypertension"},{"key":"2025063007571663200_bib31","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.matbio.2018.02.004","article-title":"Molecular and tissue alterations of collagens in fibrosis","volume":"69","author":"Ricard-Blum","year":"2018","journal-title":"Matrix Biol"},{"key":"2025063007571663200_bib32","doi-asserted-by":"publisher","first-page":"C216","DOI":"10.1152\/ajpcell.00328.2012","article-title":"Cellular mechanisms of tissue fibrosis. 1. Common and organ-specific mechanisms associated with tissue fibrosis","volume":"304","author":"Zeisberg","year":"2013","journal-title":"Am J Physiol Cell Physiol"},{"key":"2025063007571663200_bib33","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.molmed.2019.02.006","article-title":"Surviving acute organ failure: cell polyploidization and progenitor proliferation","volume":"25","author":"Lazzeri","year":"2019","journal-title":"Trends Mol Med"},{"key":"2025063007571663200_bib34","doi-asserted-by":"publisher","first-page":"2592","DOI":"10.1161\/CIRCULATIONAHA.109.886473","article-title":"Cardiorenal syndrome: new perspectives","volume":"121","author":"Bock","year":"2010","journal-title":"Circulation"},{"key":"2025063007571663200_bib35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2015\/391790","article-title":"Oxidative stress: dual pathway induction in cardiorenal syndrome type 1 pathogenesis","volume":"2015","author":"Virzi","year":"2015","journal-title":"Oxid Med Cell Long"},{"key":"2025063007571663200_bib36","doi-asserted-by":"publisher","first-page":"1605358","DOI":"10.1155\/2020\/1605358","article-title":"Characterization of the oxidative stress in renal ischemia\/reperfusion-induced cardiorenal syndrome type 3","volume":"2020","author":"Caio-Silva","year":"2020","journal-title":"Biomed Res Int"},{"key":"2025063007571663200_bib37","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1097\/01.ASN.0000064946.94590.46","article-title":"Distant effects of experimental renal ischemia\/reperfusion injury","volume":"14","author":"Kelly","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"2025063007571663200_bib38","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1007\/s00395-024-01056-y","article-title":"Chronic kidney disease activates the HDAC6-inflammatory axis in the heart and contributes to myocardial remodeling in mice: inhibition of HDAC6 alleviates chronic kidney disease-induced myocardial remodeling","volume":"119","author":"Kundu","year":"2024","journal-title":"Basic Res Cardiol"},{"key":"2025063007571663200_bib39","doi-asserted-by":"publisher","first-page":"2766","DOI":"10.1093\/ndt\/gft376","article-title":"Role of inflammation in the pathogenesis of cardiorenal syndrome in a rat myocardial infarction model","volume":"28","author":"Cho","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"2025063007571663200_bib40","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.ijcard.2020.04.015","article-title":"Inhibition of apoptosis signal-regulating kinase 1 ameliorates left ventricular dysfunction by reducing hypertrophy and fibrosis in a rat model of cardiorenal syndrome","volume":"310","author":"Savira","year":"2020","journal-title":"Int J Cardiol"},{"key":"2025063007571663200_bib41","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/j.kint.2018.11.021","article-title":"Wnt\/beta-catenin signaling mediates both heart and kidney injury in type 2 cardiorenal syndrome","volume":"95","author":"Zhao","year":"2019","journal-title":"Kidney Int"},{"key":"2025063007571663200_bib42","doi-asserted-by":"publisher","first-page":"e12765","DOI":"10.14814\/phy2.12765","article-title":"TNF\/Ang-II synergy is obligate for fibroinflammatory pathology, but not for changes in cardiorenal function","volume":"4","author":"Mayr","year":"2016","journal-title":"Physiol Rep"},{"key":"2025063007571663200_bib43","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1038\/s41581-019-0110-2","article-title":"Macrophages: versatile players in renal inflammation and fibrosis","volume":"15","author":"Tang","year":"2019","journal-title":"Nat Rev Nephrol"},{"key":"2025063007571663200_bib44","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1111\/jcmm.12813","article-title":"Renalase attenuates hypertension, renal injury and cardiac remodelling in rats with subtotal nephrectomy","volume":"20","author":"Yin","year":"2016","journal-title":"J Cell Mol Med"},{"key":"2025063007571663200_bib45","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.jacbts.2017.12.006","article-title":"CCR2(+) monocyte-derived infiltrating macrophages are required for adverse cardiac remodeling during pressure overload","volume":"3","author":"Patel","year":"2018","journal-title":"JACC Basic Transl Sci"},{"key":"2025063007571663200_bib46","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1161\/CIRCULATIONAHA.106.643585","article-title":"Tumor necrosis factor-alpha mediates cardiac remodeling and ventricular dysfunction after pressure overload state","volume":"115","author":"Sun","year":"2007","journal-title":"Circulation"},{"key":"2025063007571663200_bib47","doi-asserted-by":"publisher","first-page":"F777","DOI":"10.1152\/ajprenal.2001.280.5.F777","article-title":"Contributions of angiotensin II and tumor necrosis factor-alpha to the development of renal fibrosis","volume":"280","author":"Guo","year":"2001","journal-title":"Am J Physiol Renal Physiol"},{"key":"2025063007571663200_bib48","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1080\/15592294.2017.1370173","article-title":"A novel acetyltransferase p300 inhibitor ameliorates hypertension-associated cardio-renal fibrosis","volume":"12","author":"Rai","year":"2017","journal-title":"Epigenetics"},{"key":"2025063007571663200_bib49","doi-asserted-by":"publisher","first-page":"775029","DOI":"10.3389\/fphys.2021.775029","article-title":"Fibroblast growth factor-23-Klotho axis in cardiorenal syndrome: mediators and potential therapeutic targets","volume":"12","author":"Navarro-Garcia","year":"2021","journal-title":"Front Physiol"},{"key":"2025063007571663200_bib50","doi-asserted-by":"publisher","first-page":"e016041","DOI":"10.1161\/JAHA.120.016041","article-title":"Clinical potential of targeting fibroblast growth factor-23 and \u03b1Klotho in the treatment of uremic cardiomyopathy","volume":"9","author":"Law","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"2025063007571663200_bib51","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.tips.2023.06.001","article-title":"Targeting galectin-3 in inflammatory and fibrotic diseases","volume":"44","author":"Bouffette","year":"2023","journal-title":"Trends Pharmacol Sci"},{"key":"2025063007571663200_bib52","doi-asserted-by":"publisher","first-page":"12","DOI":"10.5812\/cardiovascmed.28952","article-title":"Galectin-3 serum levels are independently associated with microalbuminuria in chronic heart failure outpatients","volume":"5","author":"Iacoviello","year":"2016","journal-title":"Res Cardiovasc Med"},{"key":"2025063007571663200_bib53","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/nrneph.2012.290","article-title":"Renal progenitors: an evolutionary conserved strategy for kidney regeneration","volume":"9","author":"Romagnani","year":"2013","journal-title":"Nat Rev Nephrol"},{"key":"2025063007571663200_bib54","doi-asserted-by":"publisher","first-page":"5805","DOI":"10.1038\/s41467-022-33110-5","article-title":"Tubular cell polyploidy protects from lethal acute kidney injury but promotes consequent chronic kidney disease","volume":"13","author":"De Chiara","year":"2022","journal-title":"Nat Commun"},{"key":"2025063007571663200_bib55","doi-asserted-by":"publisher","first-page":"S134","DOI":"10.1053\/ajkd.2001.27422","article-title":"Role of connective tissue growth factor in profibrotic action of transforming growth factor-beta: a potential target for preventing renal fibrosis","volume":"38","author":"Yokoi","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"2025063007571663200_bib56","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.jacc.2019.11.031","article-title":"Mechanisms of cardiorenal effects of sodium-glucose cotransporter 2 inhibitors: JACC state-of-the-art review","volume":"75","author":"Zelniker","year":"2020","journal-title":"J Am Coll Cardiol"}],"container-title":["Nephrology Dialysis Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ndt\/advance-article-pdf\/doi\/10.1093\/ndt\/gfaf009\/61430203\/gfaf009.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ndt\/article-pdf\/40\/7\/1273\/61430203\/gfaf009.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ndt\/article-pdf\/40\/7\/1273\/61430203\/gfaf009.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T11:57:26Z","timestamp":1751284646000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ndt\/article\/40\/7\/1273\/7953342"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,13]]},"references-count":56,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2025,1,13]]},"published-print":{"date-parts":[[2025,6,30]]}},"URL":"https:\/\/doi.org\/10.1093\/ndt\/gfaf009","relation":{},"ISSN":["0931-0509","1460-2385"],"issn-type":[{"value":"0931-0509","type":"print"},{"value":"1460-2385","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,7]]},"published":{"date-parts":[[2025,1,13]]}}}